Predict your next investment

Corporation
CONSUMER PRODUCTS & SERVICES | Tobacco
jt.com

See what CB Insights has to offer

Investments

5

Partners & Customers

10

About Japan Tobacco

Japan Tobacco is an international tobacco product company. Its products are sold in over 120 countries and its internationally recognized brands include Winston, Camel, Mevius and Benson & Hedges. With diversified operations, JT is also actively present in pharmaceuticals, beverages and processed foods.

Japan Tobacco Headquarter Location

2-1, Toranomon 2-chome Minato-ku

Tokyo, 105-8422,

Japan

+81-3-3582-3111

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Japan Tobacco Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Japan Tobacco Rank

Latest Japan Tobacco News

Japan Tobacco Considers Sale of Russian Operations

Apr 29, 2022

The market leader in Russia, JT has four factories and 4,000 employees in the country. The post Japan Tobacco Considers Sale of Russian Operations appeared first on Tobacco Reporter.

Japan Tobacco Investments

5 Investments

Japan Tobacco has made 5 investments. Their latest investment was in Tokyo eSports Gate as part of their Series A on October 10, 2021.

CBI Logo

Japan Tobacco Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/27/2021

Series A

Tokyo eSports Gate

$2.64M

Yes

3

10/21/2019

Series A - III

Subscribe to see more

$99M

Subscribe to see more

10

3/31/2017

Series A

Subscribe to see more

$99M

Subscribe to see more

10

7/15/2016

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

2/17/2016

Corporate Minority

Subscribe to see more

Subscribe to see more

10

Date

10/27/2021

10/21/2019

3/31/2017

7/15/2016

2/17/2016

Round

Series A

Series A - III

Series A

Corporate Minority

Corporate Minority

Company

Tokyo eSports Gate

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$2.64M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

10

10

10

10

Japan Tobacco Acquisitions

13 Acquisitions

Japan Tobacco acquired 13 companies. Their latest acquisition was Akij Group - Tobacco Business on August 06, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

8/6/2018

$99M

Acquired Unit

2

3/16/2018

$99M

Acquired

1

12/21/2017

Other

$99M

$510M

Acquired

1

8/22/2017

Subscribe to see more

$99M

Subscribe to see more

10

8/4/2017

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/6/2018

3/16/2018

12/21/2017

8/22/2017

8/4/2017

Investment Stage

Other

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$510M

Note

Acquired Unit

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

Japan Tobacco Partners & Customers

10 Partners and customers

Japan Tobacco has 10 strategic partners and customers. Japan Tobacco recently partnered with Orphagen Pharmaceuticals on June 6, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

6/1/2018

Partner

United States

Orphagen Pharmaceuticals and the Pharmaceutical Division of Japan Tobacco Enter into a Collaborative Agreement - Orphagen Pharmaceuticals

`` We have had a long and successful history with the pharmaceutical division of Japan Tobacco Inc. and I am delighted to be able to expand our relationship with this leading organization , '' said Scott Thacher , Orphagen Pharmaceuticals 's President and CEO .

1

10/12/2017

Licensor

Ireland

Opko Health Inks $118 Million Deal with Japan Tobacco, Inc. for Rayaldee

`` Japan Tobacco Inc. , together with its subsidiary Torii Pharmaceuticals , has a strong and growing franchise in hemodialysis and renal diseases , which makes Japan Tobacco Inc. an ideal partner to bring RAYALDEE to physicians and patients in Japan , '' said Phillip Frost , M.D. , Chairman and Chief Executive Officer of OPKO Health , Inc. .

2

10/12/2017

Licensor

United States

Opko Health Inks $118 Million Deal with Japan Tobacco, Inc. for Rayaldee

`` Japan Tobacco Inc. , together with its subsidiary Torii Pharmaceuticals , has a strong and growing franchise in hemodialysis and renal diseases , which makes Japan Tobacco Inc. an ideal partner to bring RAYALDEE to physicians and patients in Japan , '' said Phillip Frost , M.D. , Chairman and Chief Executive Officer of OPKO Health , Inc. .

4

8/10/2016

Licensor, and Licensee

United States, and Japan

Subscribe to see more

Subscribe to see more

10

1/20/2016

Vendor

France

Subscribe to see more

Subscribe to see more

10

Date

6/1/2018

10/12/2017

10/12/2017

8/10/2016

1/20/2016

Type

Partner

Licensor

Licensor

Licensor, and Licensee

Vendor

Business Partner

Country

United States

Ireland

United States

United States, and Japan

France

News Snippet

Orphagen Pharmaceuticals and the Pharmaceutical Division of Japan Tobacco Enter into a Collaborative Agreement - Orphagen Pharmaceuticals

`` We have had a long and successful history with the pharmaceutical division of Japan Tobacco Inc. and I am delighted to be able to expand our relationship with this leading organization , '' said Scott Thacher , Orphagen Pharmaceuticals 's President and CEO .

Opko Health Inks $118 Million Deal with Japan Tobacco, Inc. for Rayaldee

`` Japan Tobacco Inc. , together with its subsidiary Torii Pharmaceuticals , has a strong and growing franchise in hemodialysis and renal diseases , which makes Japan Tobacco Inc. an ideal partner to bring RAYALDEE to physicians and patients in Japan , '' said Phillip Frost , M.D. , Chairman and Chief Executive Officer of OPKO Health , Inc. .

Opko Health Inks $118 Million Deal with Japan Tobacco, Inc. for Rayaldee

`` Japan Tobacco Inc. , together with its subsidiary Torii Pharmaceuticals , has a strong and growing franchise in hemodialysis and renal diseases , which makes Japan Tobacco Inc. an ideal partner to bring RAYALDEE to physicians and patients in Japan , '' said Phillip Frost , M.D. , Chairman and Chief Executive Officer of OPKO Health , Inc. .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

2

4

10

10

Japan Tobacco Team

1 Team Member

Japan Tobacco has 1 team member, including current Chief Executive Officer, President, Mitsuomi Koizumi.

Name

Work History

Title

Status

Mitsuomi Koizumi

Chief Executive Officer, President

Current

Name

Mitsuomi Koizumi

Work History

Title

Chief Executive Officer, President

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.